-
HymonBio Products Revealed at the 2022 Israeli MDI Expo
The annual MDI Expo, Israel’s conference for medical equipment and digital medicine, was held in the Avenue Convention and Events Center of Airport City on June 14. More than 40 speakers introduced the latest development in the industry. More than 750 industry leaders attended the conference, an...Read more -
Rapid Response: HymonBio Launches Monkeypox Test Kit
In response to the growing threat of Monkeypox, HymonBio has launched a Monkeypox Test Kit (PCR fluorescent probe method) that can detect specific nucleic acid fragments of the virus. There agent uses the company’s unique MoLock and DIDC technology, suitable for accurate diagnosis of related dise...Read more -
Breaking News: Hymon Receives 3 CE Certifications for 3 Products
Using innovative technologies, HymonBio has, time and time again, overcome difficulties created by the COVID-19 epidemic. And now, for another piece of good news: HymonBio has received CE certifications for their HAEMOCERT™ Blood DNA Colorectal Cancer Screening Test, the Hymon® MULTONE™ Urogenita...Read more -
HymonBio SARS-CoV-2 Test Kit Enters the Indonesian Market
HymonBio has provided their high-quality SARS-CoV-2 Test Kit for the global fight against the COVID-19 pandemic. Once again, it has received another certification; this time, in Indonesia. This is a new market expansion after obtaining the US FDA EUA, EU CE, and Myanmar FDA. The HymonBio®...Read more -
Good News: HymonBio Has Received Myanmar FDA Certification!
With its profound technical strength, HymonBio has helped to fight the epidemic. And now, more good news: The HymonBio® SARS-CoV-2 Test Kit has been certified by the Myanmar FDA. This is a new market expansion for Hymon after obtaining the FDA EUA and EU CE certification. The HymonBio® SARS-CoV...Read more -
Dr Tammy Tan Awarded Suzhou Most Beautiful Woman in Science and Tech
Recently, Suzhou Municipal Party Committee Talent Office, Municipal Science and Technology Bureau, Municipal Human Resources and Social Security Bureau, Municipal Women’s Federation and Municipal Association for Science and Technology jointly launched a publicity campaign for the “Most Beau...Read more -
Hymon Patented Technology Paves Way in COVID-19 Rapid Detection
HymonBio is rooted in China, focusing on the research and development of precision medicine and POCT-related products, and holds a large number of patents and proprietary technologies. The R&D team has continuously expanded COVID-19 test reagent product lines, and actively and quickly respond...Read more -
HymonBio Receives EU CE for Two COVID-19 Products
HymonBio focuses on the development of precision medical industry and POCT-related products, and actively responds to domestic and international market demand, taking on social responsibilities. The research-and-development team has been continuously expanding their COVID-19 product line, and has...Read more -
HymonBio Products Shine in the 2022 Dubai Arab Health Convention
Covering an area of 200,000 square meters, the 2022 Arab Health Convention was held in Sheik Zayed Road Convention Gate Dubai UAE from January 24 to 27. Simultaneously, from January 5 to February 28, an online exhibition for the Dubai Medical Supplies in the UAE is in progress. HymonBio brought ...Read more -
FDA Warns Omicron Can Negatively Affect Antigen Detection
As of December 28, 2021, the FDA has updated how COVID-19 variants of concern (VOCs) impact the detection ability of listed molecular detection reagents. HymonBio has maintained its dynamic detection and can detect all variants, including Omicron. The FDA official website has warned that Omicron ...Read more -
Holiday Offer: COVID-19 Test Kit Looking for Global Distributors
HymonBio is a high-tech enterprise focused on research and development, production and sales of innovative molecular diagnostic reagents and POCT-related products. The innovative “one-step method” effectively solves the cumbersome procedure of SARS-CoV-2 nucleic acid extraction. Now, the nucleic ...Read more -
Hymon Respiratory Triplex Panel Test Kit Undergoing EUA Approval
On December 3rd, HymonBio’s new test kit for detecting COVID-19, influenza A, and influenza B has received approval by the US Food and Drug Administration for pre-EUA (case number PEUA210541). It is expected to become China’s first innovative nucleic acid test kit for testing these three diseases...Read more
